These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6873782)

  • 1. 4-bromo-2,5-dimethoxyamphetamine: psychoactivity, toxic effects and analytical methods.
    Delliou D
    Forensic Sci Int; 1983; 21(3):259-67. PubMed ID: 6873782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and quantitation of 4-bromo-2,5-dimethoxyamphetamine in seized blotters.
    Burrai L; Nieddu M; Palomba M; Pirisi MA
    Leg Med (Tokyo); 2015 Jan; 17(1):56-9. PubMed ID: 25248801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Bromo-2,5-dimethoxyphenethylamine: identification of a new street drug.
    Ragan FA; Hite SA; Samuels MS; Garey RE
    J Anal Toxicol; 1985; 9(2):91-3. PubMed ID: 3990254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of 4-bromo-2,5-dimethoxyamphetamine (DOB) found in illicit tablets seized in Italy].
    Furnari C; Ottaviano V; Rosati F
    Ann Ist Super Sanita; 2001; 37(2):297-300. PubMed ID: 11758288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A death due to 4-bromo-2,5-dimethoxyamphetamine.
    Winek CL; Collom WD; Bricker JD
    Clin Toxicol; 1981 Mar; 18(3):267-71. PubMed ID: 7237958
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-ethylamphetamine (DOET)].
    Shimamine M; Takahashi K; Nakahara Y
    Eisei Shikenjo Hokoku; 1989; (107):113-9. PubMed ID: 2636911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of high pressure liquid chromatography for the separation of drugs of abuse.
    Chan ML; Whetsell C; McChesney JD
    J Chromatogr Sci; 1974 Sep; 12(9):512-6. PubMed ID: 4472421
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigation and identification of the bromination products of dimethoxyamphetamines.
    Bailey K; Gagné DR; Pike RK
    J Assoc Off Anal Chem; 1976 Sep; 59(5):1162-9. PubMed ID: 965341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemical study of the hallucinogen (+-)-1-(2,5-dimethoxy-4-nitrophenyl)-2-aminopropane.
    Richter P; Morales A; Gómez-Jeria JS; Morales-Lagos D
    Analyst; 1988 Jun; 113(6):859-63. PubMed ID: 3218759
    [No Abstract]   [Full Text] [Related]  

  • 10. Bromo-DMA: the Australasian hallucinogen?
    Buhrich N; Morris G; Cook G
    Aust N Z J Psychiatry; 1983 Sep; 17(3):275-9. PubMed ID: 6580896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas chromatographic analysis of amphetamine derivatives and morpholine-related drugs.
    Canfield DV; Lorimer P; Epstein RL
    J Forensic Sci; 1977 Apr; 22(2):429-33. PubMed ID: 582039
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of 2-,3-, and 4-methoxyamphetamines and 2-,3-, and 4-methylamphetamines.
    Bailey K; Beckstead HD; Legault D; Verner D
    J Assoc Off Anal Chem; 1974 Sep; 57(5):1134-43. PubMed ID: 4413770
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct quantitative analysis of lysergic acid diethylamide (LSD) and 2, 5-dimethoxy-4-methylamphetamine (STP) on thin-layer chromatograms.
    Niwaguchi T; Inoue T
    J Chromatogr; 1976 Jun; 121(1):165-9. PubMed ID: 932131
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on radioimmunoassay for 2,5-dimethoxy-4-methylamphetamine.
    Nagamatsu K; Kido Y; Urakabo G
    Chem Pharm Bull (Tokyo); 1977 Dec; 25(12):3390-4. PubMed ID: 564751
    [No Abstract]   [Full Text] [Related]  

  • 15. Diffuse vascular spasm associated with 4-bromo-2,5-dimethoxyamphetamine ingestion.
    Bowen JS; Davis GB; Kearney TE; Bardin J
    JAMA; 1983 Mar; 249(11):1477-9. PubMed ID: 6827726
    [No Abstract]   [Full Text] [Related]  

  • 16. 2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
    Ewald AH; Maurer HH
    Toxicol Lett; 2008 Dec; 183(1-3):52-7. PubMed ID: 18938231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromo-DMA: new hallucinogenic drug.
    Delliou D
    Med J Aust; 1980 Jan; 1(2):83. PubMed ID: 7360100
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-reactivity of amphetamine analogues with Roche Abuscreen radioimmunoassay reagents.
    Cody JT
    J Anal Toxicol; 1990; 14(1):50-3. PubMed ID: 2314063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in the effects of 4-bromo-2,5-dimethoxyamphetamine (DOB) on operant behavior of squirrel monkeys.
    McKearney JW
    Pharmacol Biochem Behav; 1988 Feb; 29(2):281-5. PubMed ID: 3362922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human.
    Carmo H; Hengstler JG; de Boer D; Ringel M; Remião F; Carvalho F; Fernandes E; dos Reys LA; Oesch F; de Lourdes Bastos M
    Toxicology; 2005 Jan; 206(1):75-89. PubMed ID: 15590110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.